According to the latest report by IMARC Group, titled “Bioanalytical Testing Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global bioanalytical testing services market reached a value of US$ 2.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.90 Billion by 2027, exhibiting a CAGR of 11.31% during 2022-2027.
Market Outlook:
Bioanalytical testing refers to a branch of analytical chemistry that involves the quantitative measurement of drugs and metabolites present in multiple biological fluids, such as blood, plasma, serum, urine, or tissue extracts. It includes cell-based assays, in vitro or vivo virology testing, method development, optimization and validation, and immunogenicity as common service types. These testing methods ensure results that validate accuracy, precision, and stability. Consequently, bioanalytical testing services find extensive applications in pharmacology, bioavailability, bioequivalence, pharmacokinetic, and toxicological research.
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
Request a Free PDF Sample of the Report: https://www.imarcgroup.com/bioanalytical-testing-services-market/requestsample
Market Trends:
The increasing demand for effective biopharmaceutical products and the growing acceptance of biosimilars and generics are majorly driving the bioanalytical testing services market growth. In line with this, the rising prevalence of chronic diseases, such as diabetes and cancer, coupled with the growing pre-clinical and clinical trials for developing new drugs, are creating a positive outlook for the market. Additionally, the widespread adoption of the quality by design approach (QbD) by biotechnology companies to ensure product quality and improve their manufacturing processes is impelling the market growth. Besides this, the sudden outbreak of the COVID-19 pandemic intensified investments in research and development (R&D) activities to formulate effective treatments for early detection and screening of disease, which is aiding in the market expansion.
Major Players Covered:
- Almac Group
- Charles River Laboratories International Inc.
- Frontage Laboratories Inc.
- ICON plc
- Intertek Group plc
- Laboratory Corporation of America Holdings
- Pace Analytical Services LLC
- PPD Inc.
- PRA Health Sciences
- SGS SA
- Syneos Health
- Toxikon Corporation
Key Market Segmentation:
The report has segmented the global bioanalytical testing services market on the basis of molecule type, test type, workflow and region.
Breakup by Molecule Type:
- Small Molecule
- Large Molecule
Breakup by Test Type:
- ADME
- PK
- PD
- Bioavailability
- Bioequivalence
- Others
Breakup by Workflow:
- Sample Preparation
- Sample Analysis
- Others
Geographical Analysis:
- North America
- Asia-Pacific
- India
- Europe
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=4137&flag=C
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Contact Us:
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
Comments (0)